4//SEC Filing
CORE LABORATORIES N V 4
Accession 0001140361-13-028987
CIK 0001000229operating
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 5:16 PM ET
Size
8.2 KB
Accession
0001140361-13-028987
Insider Transaction Report
Form 4
Transactions
- Sale
Common Shares
2013-07-25$149.00/sh−300$44,700→ 48,522 total - Sale
Common Shares
2013-07-25$148.25/sh−3,948$585,291→ 44,574 total - Sale
Common Shares
2013-07-25$147.53/sh−7,400$1,091,722→ 37,174 total
Footnotes (2)
- [F1]The transaction was exectued in multiple trades at prices ranging from $148.00 to $148.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The transaction was exectued in multiple trades at prices ranging from $147.00 to $147.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001000229
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 5:16 PM ET
- Size
- 8.2 KB